Concepedia

Author

Phillip Banks

Lexicon Pharmaceuticals (United States)ORCID

Also Known As

Banks, P., Danne, Thomas, Lapuerta, Pablo, P Banks, P L Banks, P. Banks, P. L. Banks, P., Banks, PHILLIP L. BANKS, Phillip BANKS

126

Publications

3.9K

Citations

27

H-Index

46

Concepts

All Affiliations

Lexicon Pharmaceuticals (United States)The University of Texas Southwestern Medical CenterUniversity of Southern CaliforniaUniversity of TorontoDallas Diabetes Research Center
PB

About

Phillip Banks is an author at Lexicon Pharmaceuticals (United States) specializing in medicine, pharmacology, and diabetes.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1K

2

Diabetes

3

3

191

3

Health Sciences

2

2

142

4

Social Sciences

2

2

174

5

Emergency Medicine

1

1

49

Phillip Banks

×

39

Publications

3.8K

Citations

27

H-Index

YearCitations

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

Satish K. Garg, Robert R. Henry, Phillip Banks,

New England Journal of Medicine

2017

400

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

William R. Vogler, E Vélez-García, Roy S. Weiner,

Journal of Clinical Oncology

1992

370

A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis

Michael Safdi, Michael DeMicco, Charles A. Sninsky,

Gastroenterology

1995

324

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke, Dieter Hörsch, Martyn Caplin,

Journal of Clinical Oncology

2017

299

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown,

Clinical Pharmacology & Therapeutics

2012

235

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

John B. Buse, Satish K. Garg, Julio Rosenstock,

Diabetes Care

2018

218

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

Arthur Sands, Brian Zambrowicz, Julio Rosenstock,

Diabetes Care

2015

212

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

Thomas Danne, Bertrand Cariou, Phillip Banks,

Diabetes Care

2018

177

Chronic Depression

Alan F. Schatzberg, A. John Rush, Bruce A. Arnow,

Archives of General Psychiatry

2005

146

Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide

Matthew H. Kulke, Thomas M. O’Dorisio, Alexandria T. Phan,

Endocrine Related Cancer

2014

127

Page 1